213 related articles for article (PubMed ID: 2580477)
1. SSPE treated with isoprinosine: immunopathological observations.
Streletz LJ; Sethi BS; Graziani LJ; Duckett SW
Ann Neurol; 1985 Jan; 17(1):105-6. PubMed ID: 2580477
[No Abstract] [Full Text] [Related]
2. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).
Streletz LJ; Cracco J
Ann Neurol; 1977 Feb; 1(2):183-4. PubMed ID: 70187
[No Abstract] [Full Text] [Related]
3. Isoprinosine in subacute sclerosing panencephalitis.
Huttenlocher PR; Mattson RH
Neurology; 1979 Jun; 29(6):763-71. PubMed ID: 88024
[TBL] [Abstract][Full Text] [Related]
4. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
Haddad FS; Risk WS
Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
Filipowicz A; Grudzińska B
Neurol Neurochir Pol; 1987; 21(4-5):352-6. PubMed ID: 2451185
[TBL] [Abstract][Full Text] [Related]
6. Long-term study of isoprinosine in a case of subacute sclerosing panencephalitis.
De Reuck JL; Boon PA; Krahel NL
Eur Neurol; 1985; 24(5):294-7. PubMed ID: 2414109
[TBL] [Abstract][Full Text] [Related]
7. Isoprinosine therapy and SSPE.
Huttenlocker PR
Ann Neurol; 1980 Dec; 8(6):642. PubMed ID: 6163393
[No Abstract] [Full Text] [Related]
8. [Isoprinosine therapy of subacute sclerosing panencephalitis].
Goetz O
Monatsschr Kinderheilkd; 1981 Nov; 129(11):655-7. PubMed ID: 6172706
[No Abstract] [Full Text] [Related]
9. Isoprinosine in SSPE.
Addy DP
Neurology; 1980 Nov; 30(11):1255-6. PubMed ID: 6158715
[No Abstract] [Full Text] [Related]
10. Cerebrospinal fluid IgG changes in subacute sclerosing panencephalitis in the various stages of the disease and during isoprinosine therapy.
Poloni M; Rocchelli B; Lanzi G; Rosano Burgio F; Besana D
Ital J Neurol Sci; 1981 May; 2(2):177-84. PubMed ID: 6174478
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
Dyken PR; Swift A; DuRant RH
Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
[TBL] [Abstract][Full Text] [Related]
12. Use of isoprinosine in subacute sclerosing panencephalitis.
McGrath E; Rosenbloom L
Arch Dis Child; 1980 Oct; 55(10):829-30. PubMed ID: 6159826
[No Abstract] [Full Text] [Related]
13. SSPE incidence, therapy receive renewed attention.
Gunby P
JAMA; 1981 Aug; 246(9):927, 931-2. PubMed ID: 6166765
[No Abstract] [Full Text] [Related]
14. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
[No Abstract] [Full Text] [Related]
15. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
DuRant RH; Dyken PR
Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
[TBL] [Abstract][Full Text] [Related]
16. SSPE, measles virus, and the matrix protein: report of a case with unusual immunochemical findings.
Mandelbaum DE; Hall WW; Paneth N; Wolff RR; DeVivo DC
Ann Neurol; 1981 Oct; 10(4):351-4. PubMed ID: 6172078
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of subacute sclerosing panencephalitis with methisoprinol. Considerations a propos of 3 cases].
Defanti CA; Mirabile D
Riv Neurobiol; 1981; 27(34):621-5. PubMed ID: 6189177
[No Abstract] [Full Text] [Related]
18. The interferon system in subacute sclerosing panencephalitis and its response to isoprinosine.
Gadoth N; Kott E; Levin S; Hahn T
Brain Dev; 1989; 11(5):308-12. PubMed ID: 2479277
[TBL] [Abstract][Full Text] [Related]
19. Inosiplex for SSPE.
Jones C
Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
[No Abstract] [Full Text] [Related]
20. Inosiplex for SSPE.
Chalmers TC; Smith H
Lancet; 1982 Jun; 1(8287):1475. PubMed ID: 6177984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
